Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-25-000062
Filing Date
2025-01-22
Accepted
2025-01-22 16:11:11
Documents
1
Period of Report
2024-01-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 16721
  Complete submission text file 0000947871-25-000062.txt   18894
Mailing Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830
Business Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 7TH CIRCLE, ZAHRAN ST. ZAHRAN PLAZA BUILDING, 4TH FLOOR AMMAN M2 11844
Business Address
Sukhtian Ghiath M. (Reporting) CIK: 0001717441 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 25546062

Mailing Address C/O INTERTRUST CORP. SVCS. (CAYMAN) LTD. 190 ELGIN AVENUE GEORGE TOWN E9 KYI-9007
Business Address C/O INTERTRUST CORP. SVCS. (CAYMAN) LTD. 190 ELGIN AVENUE GEORGE TOWN E9 KYI-9007 962 6 582 7999
GMS Ventures & Investments (Reporting) CIK: 0001804598 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 25546061